Heterogeneity of canonical prostate cancer markers across lesions in metastatic castration-resistant prostate cancer.

Authors

null

Anna S. Trigos

Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

Anna S. Trigos , Anupama Pasam , Andrisha-Jade Inderjeeth , Lachlan D. Cain , Sirui Weng , Vinita Gupta , Beate Sable , Katherine L. Paweletz , Julie M. Bailis , Yangyi Zhang , Yuzhou Feng , Angelyn Anton , Ben Tran , Catherine Mitchell , Shahneen Sandhu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 219)

DOI

10.1200/JCO.2023.41.6_suppl.219

Abstract #

219

Poster Bd #

H7

Abstract Disclosures

Similar Posters

First Author: Aishwarya Subramanian

First Author: Paul Vincent Viscuse

Poster

2024 ASCO Genitourinary Cancers Symposium

Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.

Chromatin modifications on plasma ctDNA as a tool to phenotype castration-resistant prostate cancer.

First Author: Asli Munzur